<p><strong>新加坡，2026 年 1 月 23 日（全球新聞通訊社）-- Basel Medical Group Ltd</strong>（納斯達克：BMGL）（“公司”）今天宣佈，已收到納斯達克的通知，根據公司股票在過去 30 個連續交易日的收盤買入價，公司不再符合納斯達克上市規則（“規則”）中維持每股最低買入價 1 美元的要求。</p>
<p>規則為公司提供了 180 個日曆天的合規期，以便重新獲得合規。如果在這 180 天期間內，公司證券的收盤買入價至少為 1 美元，且持續十個連續交易日，納斯達克將向您提供合規的書面確認。如果公司選擇實施反向股票拆分，必須在 2026 年 7 月 21 日到期日前的十個交易日內完成拆分，以便重新獲得合規。如果公司未能重新獲得合規，公司可能有資格獲得額外的時間。為了符合資格，公司需要滿足公開持股的市場價值的持續上市要求以及納斯達克資本市場的所有其他初始上市標準，除了買入價要求，並需要在第二個合規期內提供書面通知，表明其意圖通過必要時實施反向股票拆分來彌補缺陷。如果公司滿足這些要求，納斯達克將通知公司已獲得額外的 180 個日曆天。然而，如果工作人員認為公司無法彌補缺陷，或者公司其他方面不符合資格，納斯達克將通知其證券將面臨退市。</p>
<p>公司目前正在與專業顧問合作，準備整改計劃，以解決上述不合規問題。公司股票在納斯達克的交易目前未受到此類不合規的影響。</p>
<p><strong>關於 Basel Medical Group Ltd</strong></p>
<p>Basel Medical 是一家總部位於新加坡的骨科和創傷服務、運動醫學、骨科手術及神經外科治療、行政健康篩查服務、職業醫學、康復、心理健康和婦女健康以及普通醫療的提供者。我們的運營基地位於新加坡，診所分佈在新達城購物中心、麥克弗森路、陶波、瑪格麗特大道、淡濱尼、東大門和格倫伊格爾斯醫療中心。在過去的 20 年裏，我們的集團與大量企業建立了強大而持久的關係，特別是在建築、海洋和石油天然氣行業，這些關係支撐了我們強大的商業模式。作為一家在新加坡擁有超過 20 年業績記錄的醫療服務提供者，我們在把握新加坡及東南亞私人醫療行業的增長機會方面處於良好位置，這些機會受到老齡化人口、收入水平上升、私人保險覆蓋率增加、政府在醫療保健上的努力和支出、體育參與率上升以及新加坡作為亞洲醫療服務優質目的地的地位推動。我們的管理和醫療團隊由一批骨科和神經外科專家、全科醫生、企業財務和醫療合作專家組成。Basel Medical Group Ltd 作為我們集團的控股公司，通過位於新加坡的運營子公司開展業務。有關更多信息，請訪問公司網站：www.baselmedical.com。</p>
<p><strong>前瞻性聲明</strong></p>
<p>本公告中的某些聲明為前瞻性聲明，涉及已知和未知的風險和不確定性，並基於公司對可能影響其財務狀況、經營結果、商業戰略和財務需求的未來事件的當前預期和預測。投資者可以通過使用 “目標”、“預期”、“相信”、“估計”、“期望”、“向前看”、“打算”、“可能”、“計劃”、“潛在”、“預測”、“提議”、“尋求”、“應該”、“將”、“會” 或其他類似表達在本新聞稿中找到許多（但不是全部）這樣的聲明。公司沒有義務公開更新或修訂任何前瞻性聲明，以反映後續發生的事件或情況，或其預期的變化，除非法律要求。儘管公司相信這些前瞻性聲明中表達的預期是合理的，但無法保證這些預期會正確實現，公司提醒投資者，實際結果可能與預期結果有重大差異，並鼓勵投資者查看可能影響其未來結果的其他因素，這些因素在公司向 SEC 的備案中有所説明。</p>
<p><strong>媒體聯繫：</strong></p>
<p>Basel Medical Group Ltd</p>
<p>+65 6291 9188</p>
<p>contact@baselmedical.com</p>
<p>www.baselmedical.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1UWXhNQ00zTXpjNE5ERTNJelV3TURFek1EUTNPUT09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1UWXhNQ00zTXpjNE5ERTNJelV3TURFek1EUTNPUT09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZjRkMzljOTUtOWVkNC00NTFkLWFjNjgtMzQyNDU0ZWQ2NzdmLTUwMDEzMDQ3OS0yMDI2LTAxLTIzLWVu/tiny/Basel-Medical-Group-Ltd.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZjRkMzljOTUtOWVkNC00NTFkLWFjNjgtMzQyNDU0ZWQ2NzdmLTUwMDEzMDQ3OS0yMDI2LTAxLTIzLWVu/tiny/Basel-Medical-Group-Ltd.png"/></p>

標普全球醫療股指數 ETF - iShares

美國醫療保健供應商 ETF - iShares

標普醫療保健服務 ETF - SPDR

BMGL

醫療業 ETF - SPDR

醫療業 ETF - Vanguard

<p>巴塞爾醫療集團有限公司（Nasdaq: BMGL）已收到納斯達克關於未符合每股最低出價要求 1 美元的通知。該公司有 180 天的合規期來恢復合規，如果收盤出價連續十天達到 1 美元即可實現合規。公司正在考慮進行反向股票拆分，並準備整改計劃。目前，其股票交易未受到此不合規的影響</p>

<p><strong>Singapore, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd</strong> (Nasdaq: BMGL) (the “Company”), today announced that it has received notification from Nasdaq that based on the closing bid price of the Company’s shares for the last 30 consecutive business days, the Company no longer meets the requirements under Nasdaq’s Listing Rules (the “Rules”) for listed securities to maintain a minimum bid price of $1 per share.</p>
<div class="lb-trans"><p><strong>新加坡，2026 年 1 月 23 日（全球新聞通訊社）-- Basel Medical Group Ltd</strong>（納斯達克：BMGL）（“公司”）今天宣佈，已收到納斯達克的通知，根據公司股票在過去 30 個連續交易日的收盤買入價，公司不再符合納斯達克上市規則（“規則”）中維持每股最低買入價 1 美元的要求。</p>
</div><p>The Rules provide the Company a compliance period of 180 calendar days in which to regain compliance. If at any time during this 180 day period the closing bid price of the Company’s security is at least $1 for a minimum of ten consecutive business days, Nasdaq will provide you written confirmation of compliance. If the Company chooses to implement a reverse stock split, it must complete the split no later than ten business days prior to the expiration date of July 21, 2026, in order to regain compliance. In the event the Company does not regain compliance, the Company may be eligible for additional time. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company meets these requirements, Nasdaq will inform the Company that it has been granted an additional 180 calendar days. However, if it appears to Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that its securities will be subject to delisting.</p>
<div class="lb-trans"><p>規則為公司提供了 180 個日曆天的合規期，以便重新獲得合規。如果在這 180 天期間內，公司證券的收盤買入價至少為 1 美元，且持續十個連續交易日，納斯達克將向您提供合規的書面確認。如果公司選擇實施反向股票拆分，必須在 2026 年 7 月 21 日到期日前的十個交易日內完成拆分，以便重新獲得合規。如果公司未能重新獲得合規，公司可能有資格獲得額外的時間。為了符合資格，公司需要滿足公開持股的市場價值的持續上市要求以及納斯達克資本市場的所有其他初始上市標準，除了買入價要求，並需要在第二個合規期內提供書面通知，表明其意圖通過必要時實施反向股票拆分來彌補缺陷。如果公司滿足這些要求，納斯達克將通知公司已獲得額外的 180 個日曆天。然而，如果工作人員認為公司無法彌補缺陷，或者公司其他方面不符合資格，納斯達克將通知其證券將面臨退市。</p>
</div><p>The Company is currently working with its professional advisers to prepare a rectification plan to remedy the above mentioned non-compliance. Trading of the Company’s shares on Nasdaq is not currently affected by such non-compliance.</p>
<div class="lb-trans"><p>公司目前正在與專業顧問合作，準備整改計劃，以解決上述不合規問題。公司股票在納斯達克的交易目前未受到此類不合規的影響。</p>
</div><p><strong>About Basel Medical Group Ltd</strong></p>
<div class="lb-trans"><p><strong>關於 Basel Medical Group Ltd</strong></p>
</div><p>Basel Medical is a Singapore-based provider of orthopedic and trauma services, sports medicine, orthopedic procedures and surgery, as well as neurosurgical treatments, executive health screening services, occupational medicine, rehabilitation, mental and women’s health and general practices. Our operations are based in Singapore, with our clinics being located at Suntec City Mall, Macpherson Road, Toa Payoh, Margaret Drive, Tampines, Gateway East and Gleneagles Medical Centre. Over the last 20 years, our group has forged strong and lasting relationships with a large base of corporations, in particular those in the construction, marine and oil &amp; gas industries, which underpin our robust business model. As an medical service provider in Singapore with a track record of over 20 years, we are well-positioned to ride the wave of growth opportunities in the private healthcare industry in Singapore and across Southeast Asia driven by ageing populations, rising income levels, increasing private insurance coverage, government effort and expenditure on healthcare, growing sports participation rate and Singapore’s position as a premium destination for healthcare services in Asia. Our management and medical practitioner team comprises a roster of orthopedic and neurosurgery specialists, general practitioners, corporate finance and healthcare partnership specialists. Basel Medical Group Ltd serves as the holding company of our group and we conduct our operations through our operating subsidiaries based in Singapore. For more information, please visit the Company’s website: www.baselmedical.com.</p>
<div class="lb-trans"><p>Basel Medical 是一家總部位於新加坡的骨科和創傷服務、運動醫學、骨科手術及神經外科治療、行政健康篩查服務、職業醫學、康復、心理健康和婦女健康以及普通醫療的提供者。我們的運營基地位於新加坡，診所分佈在新達城購物中心、麥克弗森路、陶波、瑪格麗特大道、淡濱尼、東大門和格倫伊格爾斯醫療中心。在過去的 20 年裏，我們的集團與大量企業建立了強大而持久的關係，特別是在建築、海洋和石油天然氣行業，這些關係支撐了我們強大的商業模式。作為一家在新加坡擁有超過 20 年業績記錄的醫療服務提供者，我們在把握新加坡及東南亞私人醫療行業的增長機會方面處於良好位置，這些機會受到老齡化人口、收入水平上升、私人保險覆蓋率增加、政府在醫療保健上的努力和支出、體育參與率上升以及新加坡作為亞洲醫療服務優質目的地的地位推動。我們的管理和醫療團隊由一批骨科和神經外科專家、全科醫生、企業財務和醫療合作專家組成。Basel Medical Group Ltd 作為我們集團的控股公司，通過位於新加坡的運營子公司開展業務。有關更多信息，請訪問公司網站：www.baselmedical.com。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性聲明</strong></p>
</div><p>Certain statements in this announcement are forward-looking statements, which involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “aim”, “anticipate”, “believe”, “estimate”, “expect”, “going forward”, “intend”, “may”, “plan”, “potential”, “predict”, “propose”, “seek”, “should”, “will”, “would” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s filings with the SEC.</p>
<div class="lb-trans"><p>本公告中的某些聲明為前瞻性聲明，涉及已知和未知的風險和不確定性，並基於公司對可能影響其財務狀況、經營結果、商業戰略和財務需求的未來事件的當前預期和預測。投資者可以通過使用 “目標”、“預期”、“相信”、“估計”、“期望”、“向前看”、“打算”、“可能”、“計劃”、“潛在”、“預測”、“提議”、“尋求”、“應該”、“將”、“會” 或其他類似表達在本新聞稿中找到許多（但不是全部）這樣的聲明。公司沒有義務公開更新或修訂任何前瞻性聲明，以反映後續發生的事件或情況，或其預期的變化，除非法律要求。儘管公司相信這些前瞻性聲明中表達的預期是合理的，但無法保證這些預期會正確實現，公司提醒投資者，實際結果可能與預期結果有重大差異，並鼓勵投資者查看可能影響其未來結果的其他因素，這些因素在公司向 SEC 的備案中有所説明。</p>
</div><p><strong>Media Contact:</strong></p>
<div class="lb-trans"><p><strong>媒體聯繫：</strong></p>
</div><p>Basel Medical Group Ltd</p>
<div class="lb-trans"><p>Basel Medical Group Ltd</p>
</div><p>+65 6291 9188</p>
<div class="lb-trans"><p>+65 6291 9188</p>
</div><p>contact@baselmedical.com</p>
<div class="lb-trans"><p>contact@baselmedical.com</p>
</div><p>www.baselmedical.com</p>
<div class="lb-trans"><p>www.baselmedical.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1UWXhNQ00zTXpjNE5ERTNJelV3TURFek1EUTNPUT09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYzMTYxMCM3Mzc4NDE3IzUwMDEzMDQ3OQ=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZjRkMzljOTUtOWVkNC00NTFkLWFjNjgtMzQyNDU0ZWQ2NzdmLTUwMDEzMDQ3OS0yMDI2LTAxLTIzLWVu/tiny/Basel-Medical-Group-Ltd.png" alt="" original-src="https://ml.globenewswire.com/media/ZjRkMzljOTUtOWVkNC00NTFkLWFjNjgtMzQyNDU0ZWQ2NzdmLTUwMDEzMDQ3OS0yMDI2LTAxLTIzLWVu/tiny/Basel-Medical-Group-Ltd.png"/></p>

BMGL 股票新聞：收到來自納斯達克的拖欠通知